A novel isoform ratio switch of the polypyrimidine tract binding protein

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

In this report we present evidence for a novel switch in the ratio of the two major iso-forms of the polypyrimidine tract binding protein (PTB) in two related prostate cancer cell lines. The existence of different isoforms of PTB is thought to be the result of alternative splicing. We used UV cross-linking to identify a PTB doublet in the DT3 cell line, which is a rat prostate epithelial cancer line that is androgen-dependent and nonmetastatic. The AT3 cell line, a metastatic, androgen-independent cell line derived from the same tumor as the DT3 cells, was noted here to have a different isoform ratio of PTB. The two most prevalent isoforms of PTB were found to bind to an RNA probe containing a pyrimidine stretch. Western blot analysis demonstrated that these isoforms are indeed expressed differently in the two cell lines and that the observed binding is the result of this differential expression. These two cell lines are derived from the original Dunning prostate tumor, which is a model for studying tumor progression in the prostate. This ratio switch may be an important event in tumor progression in this model system of prostate cancer.

Original languageEnglish (US)
Title of host publicationFrom Genome to Proteome: Advances in the Practice & Application of Proteomics
PublisherWiley Blackwell
Pages502-506
Number of pages5
ISBN (Print)9783527613489, 9783527301546
DOIs
StatePublished - Dec 26 2007
Externally publishedYes

Fingerprint

Polypyrimidine Tract-Binding Protein
Protein Isoforms
Cells
Switches
Cell Line
Tumors
Prostatic Neoplasms
Androgens
Prostate
Neoplasms
RNA Probes
Alternative Splicing
Rats
Western Blotting

Keywords

  • Alternative splicing
  • Isoforms
  • Polypyrimidine tract binding protein
  • Prostate cancer

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)

Cite this

Wagner, E., Carstens, R. P., & Garcia-Blanco, M. (2007). A novel isoform ratio switch of the polypyrimidine tract binding protein. In From Genome to Proteome: Advances in the Practice & Application of Proteomics (pp. 502-506). Wiley Blackwell. https://doi.org/10.1002/9783527613489.ch65

A novel isoform ratio switch of the polypyrimidine tract binding protein. / Wagner, Eric; Carstens, Russ P.; Garcia-Blanco, Mariano.

From Genome to Proteome: Advances in the Practice & Application of Proteomics. Wiley Blackwell, 2007. p. 502-506.

Research output: Chapter in Book/Report/Conference proceedingChapter

Wagner, E, Carstens, RP & Garcia-Blanco, M 2007, A novel isoform ratio switch of the polypyrimidine tract binding protein. in From Genome to Proteome: Advances in the Practice & Application of Proteomics. Wiley Blackwell, pp. 502-506. https://doi.org/10.1002/9783527613489.ch65
Wagner E, Carstens RP, Garcia-Blanco M. A novel isoform ratio switch of the polypyrimidine tract binding protein. In From Genome to Proteome: Advances in the Practice & Application of Proteomics. Wiley Blackwell. 2007. p. 502-506 https://doi.org/10.1002/9783527613489.ch65
Wagner, Eric ; Carstens, Russ P. ; Garcia-Blanco, Mariano. / A novel isoform ratio switch of the polypyrimidine tract binding protein. From Genome to Proteome: Advances in the Practice & Application of Proteomics. Wiley Blackwell, 2007. pp. 502-506
@inbook{d7747e5d49a14197899d43de521bc7ec,
title = "A novel isoform ratio switch of the polypyrimidine tract binding protein",
abstract = "In this report we present evidence for a novel switch in the ratio of the two major iso-forms of the polypyrimidine tract binding protein (PTB) in two related prostate cancer cell lines. The existence of different isoforms of PTB is thought to be the result of alternative splicing. We used UV cross-linking to identify a PTB doublet in the DT3 cell line, which is a rat prostate epithelial cancer line that is androgen-dependent and nonmetastatic. The AT3 cell line, a metastatic, androgen-independent cell line derived from the same tumor as the DT3 cells, was noted here to have a different isoform ratio of PTB. The two most prevalent isoforms of PTB were found to bind to an RNA probe containing a pyrimidine stretch. Western blot analysis demonstrated that these isoforms are indeed expressed differently in the two cell lines and that the observed binding is the result of this differential expression. These two cell lines are derived from the original Dunning prostate tumor, which is a model for studying tumor progression in the prostate. This ratio switch may be an important event in tumor progression in this model system of prostate cancer.",
keywords = "Alternative splicing, Isoforms, Polypyrimidine tract binding protein, Prostate cancer",
author = "Eric Wagner and Carstens, {Russ P.} and Mariano Garcia-Blanco",
year = "2007",
month = "12",
day = "26",
doi = "10.1002/9783527613489.ch65",
language = "English (US)",
isbn = "9783527613489",
pages = "502--506",
booktitle = "From Genome to Proteome: Advances in the Practice & Application of Proteomics",
publisher = "Wiley Blackwell",

}

TY - CHAP

T1 - A novel isoform ratio switch of the polypyrimidine tract binding protein

AU - Wagner, Eric

AU - Carstens, Russ P.

AU - Garcia-Blanco, Mariano

PY - 2007/12/26

Y1 - 2007/12/26

N2 - In this report we present evidence for a novel switch in the ratio of the two major iso-forms of the polypyrimidine tract binding protein (PTB) in two related prostate cancer cell lines. The existence of different isoforms of PTB is thought to be the result of alternative splicing. We used UV cross-linking to identify a PTB doublet in the DT3 cell line, which is a rat prostate epithelial cancer line that is androgen-dependent and nonmetastatic. The AT3 cell line, a metastatic, androgen-independent cell line derived from the same tumor as the DT3 cells, was noted here to have a different isoform ratio of PTB. The two most prevalent isoforms of PTB were found to bind to an RNA probe containing a pyrimidine stretch. Western blot analysis demonstrated that these isoforms are indeed expressed differently in the two cell lines and that the observed binding is the result of this differential expression. These two cell lines are derived from the original Dunning prostate tumor, which is a model for studying tumor progression in the prostate. This ratio switch may be an important event in tumor progression in this model system of prostate cancer.

AB - In this report we present evidence for a novel switch in the ratio of the two major iso-forms of the polypyrimidine tract binding protein (PTB) in two related prostate cancer cell lines. The existence of different isoforms of PTB is thought to be the result of alternative splicing. We used UV cross-linking to identify a PTB doublet in the DT3 cell line, which is a rat prostate epithelial cancer line that is androgen-dependent and nonmetastatic. The AT3 cell line, a metastatic, androgen-independent cell line derived from the same tumor as the DT3 cells, was noted here to have a different isoform ratio of PTB. The two most prevalent isoforms of PTB were found to bind to an RNA probe containing a pyrimidine stretch. Western blot analysis demonstrated that these isoforms are indeed expressed differently in the two cell lines and that the observed binding is the result of this differential expression. These two cell lines are derived from the original Dunning prostate tumor, which is a model for studying tumor progression in the prostate. This ratio switch may be an important event in tumor progression in this model system of prostate cancer.

KW - Alternative splicing

KW - Isoforms

KW - Polypyrimidine tract binding protein

KW - Prostate cancer

UR - http://www.scopus.com/inward/record.url?scp=84956506919&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84956506919&partnerID=8YFLogxK

U2 - 10.1002/9783527613489.ch65

DO - 10.1002/9783527613489.ch65

M3 - Chapter

AN - SCOPUS:84956506919

SN - 9783527613489

SN - 9783527301546

SP - 502

EP - 506

BT - From Genome to Proteome: Advances in the Practice & Application of Proteomics

PB - Wiley Blackwell

ER -